NCT01952548View on ClinicalTrials.gov

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2013

Conditions
Safety and Tolerability
Interventions
DRUG

K-312

DRUG

Placebo

Trial Locations (1)

Unknown

Austin

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY